↓ Skip to main content

Essential Reviews in Geriatric Psychiatry

Overview of attention for book
Essential Reviews in Geriatric Psychiatry
Springer International Publishing

Table of Contents

  1. Book Overview
  2. Chapter 1 Do Atypical Antipsychotics Cause Stroke?
  3. Chapter 2 Risk of Death with Atypical Antipsychotic Drug Treatment for Dementia: Meta-analysis of Randomized Placebo-Controlled Trials
  4. Chapter 3 Meta-analysis of the Impact of Nine Medication Classes on Falls in Elderly Persons
  5. Chapter 4 The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-analysis of Randomized Placebo-Controlled Trials
  6. Chapter 5 Do Antipsychotics Lead to Cognitive Impairment in Dementia? A Meta-analysis of Randomized Placebo-Controlled Trials
  7. Chapter 6 A Systematic Review and Meta-analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias
  8. Chapter 7 Treatment of Panic Disorder in Older Adults: A Pilot Study Comparison of Alprazolam, Imipramine, and Placebo
  9. Chapter 8 Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results from an 8-Week Randomized, Placebo-Controlled Trial
  10. Chapter 9 Efficacy and Tolerability of Duloxetine in Elderly Patients with Generalized Anxiety Disorder: A Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Studies
  11. Chapter 10 Escitalopram for Older Adults with Generalized Anxiety Disorder: A Randomized Controlled Trial
  12. Chapter 11 Meta-analysis Comparing Different Behavioral Treatments for Late-Life Anxiety
  13. Chapter 12 Cognitive Behavior Therapy for Generalized Anxiety Disorder Among Older Adults in Primary Care: A Randomized Clinical Trial
  14. Chapter 13 Stepped-Care Prevention of Anxiety and Depression in Late Life: A Randomized Controlled Trial
  15. Chapter 14 A Randomized Controlled Study of Paroxetine and Cognitive Behavioral Therapy for Late-Life Panic Disorder
  16. Chapter 15 Antidepressant Medication Augmented with Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
  17. Chapter 16 A Meta-Analysis of Cognitive Functioning in Older Adults with PTSD
  18. Chapter 18 A Pilot Study of Standardized Treatment in Geriatric Bipolar Disorder
  19. Chapter 19 Differences in Clinical Features and Mental Health Service Use in Bipolar Disorder Across the Life Span
  20. Chapter 20 Effect of Antidepressant Use on Admissions to Hospital Among Elderly Bipolar Patients
  21. Chapter 21 GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients with Bipolar Disorder
  22. Chapter 22 History of Bipolar Disorder and the Risk of Dementia: A Systematic Review and Meta-Analysis
  23. Chapter 23 A Multicomponent Intervention to Prevent Delirium in Hospitalized Older Patients
  24. Chapter 24 Delirium in Elderly Patients and the Risk of Post-Discharge Mortality, Institutionalization, and Dementia: A Meta-Analysis
  25. Chapter 25 Effectiveness of Multicomponent Nonpharmacological Delirium Interventions: A Meta-Analysis
  26. Chapter 26 Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis
  27. Chapter 27 Interventions for Preventing Delirium in Older People in Institutional Long-Term Care
  28. Chapter 28 Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression: A Randomized Controlled Trial in Patients Older than 59 Years
  29. Chapter 29 Continuation Treatment of Delusional Depression in Older Adults
  30. Chapter 30 Reducing Suicidal Ideation and Depressive Symptoms in Depressed Older Primary Care Patients: A Randomized Controlled Trial
  31. Chapter 31 Remission in Depressed Geriatric Primary Care Patients: A Report from the PROSPECT Study
  32. Chapter 32 Executive Dysfunction and the Course of Geriatric Depression
  33. Chapter 33 Maintenance Treatment of Major Depression in Old Age
  34. Chapter 34 Placebo-Controlled Study of Relapse Prevention with Risperidone Augmentation in Older Patients with Resistant Depression
  35. Chapter 35 Efficacy of Second-Generation Antidepressants in Late-Life Depression: A Meta-analysis of the Evidence
  36. Chapter 36 A Double-Blind Randomized Controlled Trial of Olanzapine Plus Sertraline Versus Olanzapine Plus Placebo for Psychotic Depression: The Study of Pharmacotherapy of Psychotic Depression (STOP-PD)
  37. Chapter 37 Speed of Remission in Elderly Patients with Depression: Electroconvulsive Therapy Versus Medication
  38. Chapter 38 A Systematic Review and Meta-analysis of Psychotherapy for Late-Life Depression
  39. Chapter 39 A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study
  40. Chapter 40 Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study
  41. Chapter 41 Improvement in Depression Is Associated with Improvement in Cognition in Late-Life Psychotic Depression
  42. Chapter 42 Continuation/Maintenance Treatment with Nortriptyline Versus Combined Nortriptyline and ECT in Late-Life Psychotic Depression: A Two-Year Randomized Study
  43. Chapter 43 Safety and Utility of Acute Electroconvulsive Therapy for Agitation and Aggression in Dementia
  44. Chapter 44 Electroconvulsive Therapy and Risk of Dementia in Patients with Affective Disorders: A Cohort Study
  45. Chapter 45 Electroconvulsive Therapy and Risk of Dementia: A Nationwide Cohort Study in Taiwan
  46. Chapter 46 Treatment of Complicated Grief in Elderly Persons: A Randomized Clinical Trial
  47. Chapter 47 Association Between Psychological Interventions and Chronic Pain Outcomes in Older Adults: A Systematic Review and Meta-Analysis
  48. Chapter 48 A Randomized Controlled Trial of Cognitive Behavioral Social Skills Training for Middle-Aged and Older Outpatients with Chronic Schizophrenia
  49. Chapter 49 Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients with Schizophrenia: A Double-Blind, Placebo-Controlled Study with Six-Month Open-Label Extension
  50. Chapter 50 Antipsychotic Treatment for Elderly People with Late-Onset Schizophrenia
  51. Chapter 51 Schizophrenia and Risk of Dementia: A Meta-Analysis Study
  52. Chapter 52 Antipsychotic Treatment of Very Late-Onset Schizophrenia-Like Psychosis (ATLAS): A Randomized, Controlled, Double-Blind Trial
  53. Chapter 54 Depression and Risk for Alzheimer’s Disease: Systematic Review, Meta-analysis, and Metaregression Analysis
  54. Chapter 55 Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer’s Disease
  55. Chapter 56 Predictors of Progression from Mild Cognitive Impairment to Alzheimer’s Disease
  56. Chapter 57 Efficacy and Safety of Cognitive Enhancers for Patients with Mild Cognitive Impairment: A Systematic Review and Meta-analysis
  57. Chapter 58 Personality and Risk of Alzheimer’s Disease: New Data and Meta-analysis
  58. Chapter 59 Modifiable Predictors of Dementia in Mild Cognitive Impairment: A Systematic Review and Meta-analysis
  59. Chapter 61 Meta-analysis of Modifiable Risk Factors of Alzheimer’s Disease
  60. Chapter 62 Memantine for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis
  61. Chapter 63 Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-analysis
  62. Chapter 64 Pharmacological Interventions for Apathy in Alzheimer’s Disease
  63. Chapter 65 Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
  64. Chapter 66 Cognitive Behavioral Therapy Versus Zopiclone for the Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial
  65. Chapter 67 Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials
  66. Chapter 68 Cognitive Behavioral Therapy for Older Adults with Insomnia and Depression: A Randomized Controlled Trial in Community Mental Health Services
  67. Chapter 69 Medical Illness and the Risk of Suicide in the Elderly
  68. Chapter 70 The Risk of Suicide with Selective Serotonin Reuptake Inhibitors in the Elderly
  69. Chapter 71 Naltrexone as an Adjunctive Treatment for Older Patients with Alcohol Dependence
  70. Chapter 72 Older Adult Patients with Both Psychiatric and Substance Abuse Disorders: Prevalence and Health Service Use
  71. Chapter 73 Five-Year Alcohol and Drug Treatment Outcomes of Older Adults Versus Middle-Aged and Younger Adults in a Managed Care Program
  72. Chapter 74 Treatment of Late-Life Depression Complicated by Alcohol Dependence
  73. Chapter 75 Screening and Brief Intervention for Substance Misuse Among Older Adults: The Florida BRITE Project
Overall attention for this book and its chapters

Mentioned by

twitter
1 X user

Readers on

mendeley
41 Mendeley